Privia Health (PRVA) Fundamental Analysis: Revenue, Earnings & Valuation

6.87 / 10

Outperform

Fundamental evaluation yields a 6.87/10 score and Outperform rating. Key strengths include strong Revenue‑MV, robust operating cash‑flow growth, and high profit growth; weaknesses are low inventory turnover and poor net‑income‑to‑revenue ratio. Overall fundamentals are satisfactory.

Analysis Checks(5/10)

Revenue-MV

Value0.44

Score3/3

Weight34.85%

1M Return6.67%

Net cash flow from operating activities per share (YoY growth rate %)

Value45.54

Score2/3

Weight16.25%

1M Return3.60%

Inventory turnover ratio

Value106.57

Score1/3

Weight7.40%

1M Return1.74%

Net income-Revenue

Value-1.86

Score0/3

Weight-8.92%

1M Return-2.25%

Basic earnings per share (YoY growth rate %)

Value58.33

Score1/3

Weight4.34%

1M Return0.92%

Total profit (YoY growth rate %)

Value57.65

Score3/3

Weight27.70%

1M Return5.90%

Net cash flow from operating activities (YoY growth rate %)

Value49.53

Score2/3

Weight17.34%

1M Return3.84%

Cash-UP

Value0.64

Score1/3

Weight3.28%

1M Return0.84%

Diluted earnings per share (YoY growth rate %)

Value63.64

Score2/3

Weight6.96%

1M Return1.55%

Cash-MV

Value0.45

Score0/3

Weight-9.21%

1M Return-2.55%

Is PRVA fundamentally strong?

PRVA scores 6.87/10 on fundamentals and holds a Discounted valuation at present. Backed by its 3.11% ROE, 1.40% net margin, 112.09 P/E ratio, 3.25 P/B ratio, and 58.33% earnings growth, these metrics solidify its Outperform investment rating.